DRIVEN RESULTS BPC-157 + Epicatechin BPC Epicatechin BPC-157 FlexMax supports recovery, Gut Health, and long-term wellness
Retatrutide E_max at GIPR 103%, GLP-1R 110%, GCGR 104% of native peptide peak (full agonist at all three at cAMP signaling per the conclusions section: "LY3437943 is a full agonist at the GCGR, GIPR, and GLP-1R in the functional assays")
Both can be administered intranasally or subcutaneously and the reconstitution approach differs by route
That means that theres no maximum daily dose thats known to cause adverse effects to the general population
Feron, O., Dessy, C., Desager, J
In practice, this combination would need to be evaluated by a supervising physician with careful monitoring